Site Contract Manager (Korean/Japanese) at IQVIA

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Clinical Research, Pharmaceuticals, HealthcareIndustries

Requirements

Not specified (proficiency in Korean and/or Japanese implied by job title)

Responsibilities

Negotiate and finalize clinical trial agreements and ancillary agreements
Conduct direct negotiation with clinical trial sites or oversee CRO contract negotiations
Review and analyze contractual terms and conditions with global teams and CCS team
Assess legal and budget risks in conjunction with team support functions and CCS team
Partner with Healthcare Compliance, Risk Management, Privacy, legal, and other stakeholders
Escalate issues as appropriate
Analyze investigator fees in relation to fair market value pricing and ensure alignment with regional standards
Participate in and/or lead approval escalations
Provide support for negotiations in confidentiality agreements, informed consent forms, and other ancillary contract documents
Participate in discussions related to the development of site/investigator budgets aligned with fair market value
Manage the contract amendment lifecycle, including determining potential needs for amendments
Proactively recommend improvements to processes to reduce cycle time, create savings, and improve efficiency in clinical trial site initiation
Assume responsibility for all aspects of legal document and metrics tracking
Provide support to review, authorize, and/or understand aspects of site payments
Assist clinical operations or clinical team in ensuring that investigator grants comply with overall study costs and compliance guidelines

Skills

Contract Negotiation

Clinical Trial Agreements

Ancillary Agreements

Legal Risk Assessment

Budget Analysis

Fair Market Value Pricing

Stakeholder Management

Contract Amendments

Korean

Japanese

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free